Absence of risk of human immunodeficiency virus (HIV) infection in recipients of hepatitis B vaccine
Amoroso, P.; Izzo, C.; Smeraglia, R.; Lettieri, G.; Maio, G.; Flaminio, G.; Giorgio, A.; Fico, P.; Pierri, P.; Tarro, G.
European Journal of Epidemiology 3(3): 323-324
1987
ISSN/ISBN: 0393-2990 PMID: 2958361 DOI: 10.1007/bf00149746Document Number: 357162
Document emailed within 0-6 h
Related Documents
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
Antono, S.K.; Raya, R.P.; Irda Sari, S.Y.; Afriandi, I.; Anwar, A.D.; Setiabudi, D.; Meheus, A.; De Schryver, A.; Pinxten, L. 2010: Occupational risk for human immunodeficiency virus, hepatitis B, and hepatitis C infection in health care workers in a teaching hospital in Indonesia American Journal of Infection Control 38(9): 757-758
Solomon, S.S.; Celentano, D.D.; Srikrishnan, A.K.; Vasudevan, C.K.; Murugavel, K.G.; Iqbal, S.H.; Anand, S.; Kumar, M.S.; Latkin, C.; Solomon, S.; Mehta, S.H. 2010: Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India American Journal of Epidemiology 172(11): 1259-1267
Diendéré, E.A.; Tiéno, H.; Bognounou, R.; Ouédraogo, D.D.; Simporé, J.; Ouédraogo-Traoré, R.; Drabo, J. 2011: Prevalence and risk factors associated with infection by human immunodeficiency virus, hepatitis B virus, syphilis and bacillary pulmonary tuberculosis in prisons in Burkina Faso Medecine Tropicale: Revue du Corps de Sante Colonial 71(5): 464-467
El-Ghazzawi, E.; Drew, L.; Hamdy, L.; El-Sherbini, E.; Sadek, S.e.-D.; Saleh, E. 1995: Intravenous drug addicts: a high risk group for infection with human immunodeficiency virus, hepatitis viruses, cytomegalo virus and bacterial infections in Alexandria Egypt Journal of the Egyptian Public Health Association 70(1-2): 127-150
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Darney, P.D.; Myhra, W.; Atkinson, E.S.; Meier, J. 1989: Sero survey of human immunodeficiency virus infection in women at a family planning clinic: absence of infection in an indigent population in San Francisco American Journal of Public Health 79(7): 883-885
Evans, B.A.; Mccormack, S.M.; Bond, R.A.; Macrae, K.D.; Thorp, R.W. 1988: Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic British Medical Journal 296(6620): 473-475
Del Olmo, J.A.; Añón, C.; Llovet, F.; Serra, M.A.; Wassel, A.; Rodrigo, J.M. 1995: Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992 Gastroenterologia y Hepatologia 18(8): 405-409
Panlilio, A.L.; Shapiro, C.N.; Schable, C.A.; Mendelson, M.H.; Montecalvo, M.A.; Kunches, L.M.; Perry, S.W.; Edwards, J.R.; Srivastava, P.U.; Culver, D.H. 1995: Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group Journal of the American College of Surgeons 180(1): 16-24
Sunthornchart, S.; Linkins, R.W.; Natephisarnwanish, V.; Levine, W.C.; Maneesinthu, K.; Lolekha, R.; Tappero, J.W.; Trirat, N.; Muktier, S.; Chancharastong, P.; Fox, K.; Donchalermpak, S.; Vitek, C.; Supawitkul, S. 2008: Prevalence of hepatitis B, tetanus, hepatitis A, human immunodeficiency virus and feasibility of vaccine delivery among injecting drug users in Bangkok, Thailand, 2003-2005 Addiction 103(10): 1687-1695
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Bassa, A.; Villalonga, C.; Parras, F.; Salvà, F.; Altés, J.; Salas, A. 1989: Infection caused by the human immunodeficiency virus, hepatitis B virus and delta virus in homosexual males Medicina Clinica 93(13): 490-492
Cupps, T.R.; Tibbles, J.; Hurni, W.M.; Miller, W.J.; Ellis, R.W.; Milich, D.; Wetter, N. 1993: In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site Journal of Immunology 151(6): 3353-3360
Parande, M.V.; Mantur, B.G.; Parande, A.M.; Shinde, R.S.; Roy, S.; Jnaneshwar, K.B.; Chandrashekhar, M.R. 2013: Seroprevalence of human immunodeficiency virus and hepatitis B virus co-infection in Belgaum, southern India Indian Journal of Medical Research 138(3): 364-365